Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries

Human Reproduction

Volumn 13, Issue 3, 1998, Pages 651-655

  Agrawal, Rina ^a,b   Sladkevicius, P ^b,c   Engmann, L ^b   Conway, G S ^a   Payne, N N ^a   Bekis, J ^b   Tan, S L ^b,d   Campbell, S ^b,c   Jacobs, H S ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Hallam Medical Centre   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Doppler blood flow velocity; Polycystic ovarian syndrome; Polycystic ovary; Vascular endothelial growth factor

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; NORMAL HUMAN; OVARY BLOOD FLOW; OVARY POLYCYSTIC DISEASE; TESTOSTERONE BLOOD LEVEL;

FALLOPIA;

EID: 0031942813     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.3.651     Document Type: Article

References (41)

1. Abramov, Y., Barak, V., Nisman, B. et al. (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril., 67, 261-265.
2. Adams, J., Poison, D.W., Abdulwadi, D.V. et al. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet, 28, 1375-1379.
3. Adashi, E.Y., Rock, J.A. and Rosenwaks, Z. (1995) Reproductive Endocrinology, Surgery and Technology. Lippincott-Raven Publishers, Philadelphia, PA, USA.
4. Aleem, F.A. and Predanic, M. (1996) Transvaginal colour Doppler determination of uterine blood flow characteristics in PCOD. Fertil. Steril., 65, 510-516.
5. Balen, A.H., Conway, O.S., Kaltsas, G. et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod., 10, 2107-2111.
6. Battaglia, C., Artini, P.G., D'Ambrogio, G. et al. (1995) The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am. J. Obstet. Gynecol., 172, 108-113.
7. Connolly, D.T. (1991) Vascular permeability factor: a unique regulator of blood vessel function. J. Cell Biochem., 47, 219-223.
8. Conway, G.S., Honour, J.W. and Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol., 30, 459-470.
9. de Ziegler, D., Bessis, R. and Frydman, R. (1991) Vascular resistance of uterine arteries; physiological effects of estradiol and progesterone. Fertil. Steril., 55, 775-779.
10. Dvorak, H.F., Brown, L.F., Delmer, M. et al. (1995) Vascular permeability factor/vascular endothelial growth factor microvascular hyperpermeability and angiogenesis. Am. J. Pathol., 145, 1029-1039.
11. Elchalal, U. and Schenker, J. (1997) The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum. Reprod., 12, 1129-1137.
12. Ferrara, N. and Davis-Smith, T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev., 18, 14-25.
13. Ferrara, N. and Henzel, W.J. (1989) Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161, 851-858.
14. Findlay, J.K. (1986) Angiogenesis in reproductive tissues. J. Endocrinol., 111, 357-366.
15. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem., 267, 10931-10934.
16. Fox, R., Corrigan, E., Thomas, P. et al. (1991) The diagnosis of polycystic ovary in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin. Endocrinol., 34, 127-131.
17. Gordon, J.D., Mesiano, S., Zoloudek. C.J. et al. (1996) Vascular endothelial growth factor localization in human ovary and fallopian tubes. Possible role in human reproduction and ovarian cyst formation. J. Clin. Endocrinol. Metab., 81, 353-359.
18. Gosling, R.G., Dunbar, G., King, D.H. et al. (1971) The quantitative analysis of occlusive peripheral arterial disease by a non-intrusive ultrasonic technique. Angiology, 22, 52-55.
19. Gospodarowicz, D. (1974) Localisation of fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature, 249, 123-127.
20. Gospodarowicz, D., Abraham, J.A. and Schilling, J. (1989) Isolation and characterisation of a vascular endothelial cell mitogen produced by pituitary derived folliculostellate cells. Proc. Natl. Acad. Sci, USA, 86, 7311-7315.
21. Kamat, B.R., Brown, L.F., Manseau, E.J. et al. (1995) Expression of vascular endothelial growth factor vascular permeability factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol., 146, 157-165.
22. Klagsbrun, M. and D'Armore, P.A. (1991) Regulators of angiogenesis. Annu. Rev. Physiol., 53, 217-239.
23. Koos, R.D. (1995) Increased expression of vascular endothelial growth factor/ vascular permeability factor in the rat ovary following an ovulatory gonadotrophin stimulus: potential role in follicle rupture. Biol. Reprod., 52, 1426-1435.
24. Krasnow, J.S., Berga, S.L., Guzick, D.S. et al. (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril., 65, 552-555.
25. Leung, D., Cachianes, G., Kuang, W. et al. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1309-1312.
26. MacDougall, M.J., Tan, S.L., Balen, A. et al. (1993) A controlled study comparing patients with or without polycystic ovaries undergoing in-vitro fertilization. Hum. Reprod., 8, 233-237.
27. McClure, N., Healy, D.L., Paw, R. et al. (1994) Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235-236.
28. Neulen, J., Zhaoping, Y., Raczek, S. et al. (1995) Human chorionic gonadotrophin dependent expression of vascular endothelial growth factor in human granulosa cells and importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab., 80, 1967-1971.
29. Pepper, H.S., Vassali, J.D., Orci, L. et al. (1993) Biphasic effect of TGF-α and β on in vitro angiogenesis. Exp. Cell Res., 204, 356-363.
30. Phillips, H.S., Hains, J., Leung, D.W. et al. (1990) Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology, 127, 965-967.
31. Rizk, B. (1991) Ovarian hyperstimulation syndrome. In Brinsden, P.R. and Ransburg, P.A. (eds), Bourne Hall Textbook of In Vitro Fertilisation and Assisted Conception. Parthenon Publishing. London, UK, Chapter 23, 369-383.
32. Rizk, B., Aboulghar, M., Smitz, J. et al. (1997) The role of vascular endothelial growth factor amd interleukins in the pathogenesis of severe ovarian hyperstimuiation syndrome. Hum. Reprod. Update, 3, 255-266.
33. Robertson, D., Selleck, K., Suikkari, A.M. et al. (1995) Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment. Mol. Hum. Reprod., 10, 2478-2482.
34. Senger, D.R., Van Der Water, L., Brown, L. et al. (1983) VPF (VEGF) in tumour biology. Cancer Metab. Rev., 12, 303-324.
35. Senger, D.R., Galli, S.J., Dvorak, A.M. et al. (1993) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science, 219, 983-985.
36. Shweiki, D., Itin, A., Neufeld, G. et al. (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest., 91, 2235-2243.
37. Sladkevicius, P., Valentin, L. and Marsal, K. (1993) Blood flow velocity in the uterine and ovarian arteries during the normal menstrual cycle. Ultrasound Obstet. Gynecol., 3, 199-208.
38. Steer, C.V., Campbell, S., Pampiglione, J.S. et al. (1990) Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum. Reprod., 5, 391-395.
39. Van Blerkom, J., Antczak, M. and Schrader, R. (1997) The development potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum. Reprod., 12, 1047-1055.
40. Zaidi, J., Jurkovic, D., Campbell, S. et al. (1995a) Description of circadian rhythms in uterine artery blood flow during the pre-ovulatory period. Hum. Reprod., 10, 1642-1646.
41. Zaidi, J., Campbell. S., Pitroff, R. et al. (1995b) Ovarian stromal blood flow in women with polycystic ovaries - a possible new marker for diagnosis? Hum. Reprod., 10, 1992-1996.